Bot Image Inc.’s flagship product, ProstatIDTM is North America’s first FDA-Cleared Prostate Cancer Detection and Diagnostic AI software. With 94% accuracy, physicians can reliably detect and diagnose prostate cancer from MRI in far less interpretation time, with much higher confidence, and significantly improve their positive detection while decreasing false positives